Decision Layer
What to do with this topic
Use this page to decide whether inflammation / immune signaling belongs near the top of your follow-up list or stays in the background.
What to validate first
hsCRP, ferritin context, CBC and inflammatory context
Why this topic matters
Inflammation changes the behavior of many other pathways. The useful question is whether immune tone deserves to move into the main decision layer.
How to use this page
Use the decision layer first, then move into genes, biomarkers, and related symptom pages only if the topic still looks relevant.
Why It Rises Or Falls
How this topic earns attention
What this topic can explain
A pathway-first view keeps inflammation from becoming vague background noise. It makes hsCRP, ferritin context, and immune signaling easier to read together.
What usually moves it up the list
Inflammation / immune signaling rises when IL6 and the supporting genes point in a coherent direction, and when the follow-up markers are practical enough to check early.
What usually keeps it in the background
A topic stays lower when the signal depends too heavily on symptoms alone or when other pathways show stronger, more testable drivers.
Validation markers commonly worth checking
hsCRP
ferritin context
CBC and inflammatory context
Sample Report View
How Inflammation / immune signaling appears in the sample report
Inflammation rises when immune-tone genes align clearly enough that hsCRP and ferritin-context follow-up become easy to justify.
Moderate follow-up priority
hsCRP, ferritin context, CBC and inflammatory context
This topic is worth validating if symptoms or existing labs point in the same direction, but it is not the first place to act.